NO20084987L - Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel - Google Patents

Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel

Info

Publication number
NO20084987L
NO20084987L NO20084987A NO20084987A NO20084987L NO 20084987 L NO20084987 L NO 20084987L NO 20084987 A NO20084987 A NO 20084987A NO 20084987 A NO20084987 A NO 20084987A NO 20084987 L NO20084987 L NO 20084987L
Authority
NO
Norway
Prior art keywords
nicotine
trometamol
pharmaceutical product
buffering agent
delivery
Prior art date
Application number
NO20084987A
Other languages
English (en)
Norwegian (no)
Inventor
Per Steen
Darek Dymitrowics
Asa Waltermo
Roland Olsson
Katarina Lindell
Original Assignee
Mcneil Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=38694149&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=NO20084987(L) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Mcneil Ab filed Critical Mcneil Ab
Publication of NO20084987L publication Critical patent/NO20084987L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/465—Nicotine; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/34—Tobacco-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Psychiatry (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Physiology (AREA)
  • Addiction (AREA)
  • Hematology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
NO20084987A 2006-05-16 2008-11-27 Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel NO20084987L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
SE0601090 2006-05-16
PCT/SE2007/000365 WO2007133141A1 (fr) 2006-05-16 2007-04-18 Produit pharmaceutique enrobé destiné à une administration intrabuccale de nicotine comprenant du trométamol servant d'agent tampon

Publications (1)

Publication Number Publication Date
NO20084987L true NO20084987L (no) 2009-02-16

Family

ID=38694149

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20084987A NO20084987L (no) 2006-05-16 2008-11-27 Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel

Country Status (16)

Country Link
US (1) US20070269492A1 (fr)
EP (1) EP2023928A4 (fr)
JP (1) JP5254213B2 (fr)
KR (1) KR101414063B1 (fr)
CN (1) CN101472591A (fr)
AR (1) AR060931A1 (fr)
AU (1) AU2007250589B2 (fr)
BR (1) BRPI0712068A2 (fr)
CA (1) CA2652500C (fr)
MX (1) MX2008014726A (fr)
NO (1) NO20084987L (fr)
NZ (1) NZ572758A (fr)
RU (1) RU2448707C2 (fr)
TW (1) TW200810755A (fr)
WO (1) WO2007133141A1 (fr)
ZA (1) ZA200810618B (fr)

Families Citing this family (39)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8252321B2 (en) 2004-09-13 2012-08-28 Chrono Therapeutics, Inc. Biosynchronous transdermal drug delivery for longevity, anti-aging, fatigue management, obesity, weight loss, weight management, delivery of nutraceuticals, and the treatment of hyperglycemia, alzheimer's disease, sleep disorders, parkinson's disease, aids, epilepsy, attention deficit disorder, nicotine addiction, cancer, headache and pain control, asthma, angina, hypertension, depression, cold, flu and the like
US8642016B2 (en) 2006-07-21 2014-02-04 Jsrnti, Llc Medicinal delivery system, and related methods
CN103977003A (zh) 2007-04-02 2014-08-13 帕金森氏病研究院 用于降低治疗的副作用的方法和组合物
GB2468424B (en) * 2007-04-02 2011-11-09 Parkinson S Inst Methods and compositions for reduction of side effects of therapeutic treatments
US20080286341A1 (en) * 2007-05-16 2008-11-20 Sven-Borje Andersson Buffered coated nicotine containing products
CL2009001025A1 (es) 2008-05-01 2010-09-24 Smithkline Beecham Corp Composicion de pastilla para chupar que comprende: a) un granulo patron con al menos: un agente tampon alcalino, un modificador de la disolucion y una carga, b) un principio activo de nicotina definido extragranular y al menos un agente tampon alcalino; procedimiento de preparacion; util para eliminar o reducir el uso de tabaco.
AU2013219211B2 (en) * 2008-05-01 2016-05-12 North Star OpCo Limited Nicotine lozenge compositions
SI2177213T1 (sl) * 2008-09-17 2013-03-29 Siegfried Ltd. Nikotin vsebujoč granulat
ES2592882T3 (es) 2008-10-14 2016-12-02 Mcneil Ab Forma de dosificación intra-oral de múltiples porciones y uso de la misma
DK2198865T3 (da) * 2008-12-19 2012-01-16 Siegfried Ltd Nikotinholdigt produkt
US20100247586A1 (en) * 2009-03-27 2010-09-30 Andreas Hugerth Multi-Portion Intra-Oral Dosage Form With Organoleptic Properties
WO2010145653A1 (fr) * 2009-06-19 2010-12-23 Fertin Pharma A/S Base de gomme tamponnee pour liberation elevee de ph
CN102770138B (zh) * 2010-02-18 2015-12-09 J·V·达卡 含有尼古丁的软凝胶锭剂
US20110268809A1 (en) 2010-04-28 2011-11-03 Paul Andrew Brinkley Nicotine-Containing Pharmaceutical Compositions
US20110274628A1 (en) 2010-05-07 2011-11-10 Borschke August J Nicotine-containing pharmaceutical compositions
WO2013006643A1 (fr) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions et méthodes de traitement de symptômes chez des patients atteints de la maladie de parkinson
US9629392B2 (en) 2011-09-22 2017-04-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9084439B2 (en) 2011-09-22 2015-07-21 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US20130078307A1 (en) 2011-09-22 2013-03-28 Niconovum Usa, Inc. Nicotine-containing pharmaceutical composition
US9474303B2 (en) 2011-09-22 2016-10-25 R.J. Reynolds Tobacco Company Translucent smokeless tobacco product
US9907748B2 (en) 2011-10-21 2018-03-06 Niconovum Usa, Inc. Excipients for nicotine-containing therapeutic compositions
US20130177646A1 (en) * 2012-01-05 2013-07-11 Mcneil Ab Solid Nicotine-Comprising Dosage Form with Reduced Organoleptic Disturbance
US9763928B2 (en) 2012-02-10 2017-09-19 Niconovum Usa, Inc. Multi-layer nicotine-containing pharmaceutical composition
US9044035B2 (en) 2012-04-17 2015-06-02 R.J. Reynolds Tobacco Company Remelted ingestible products
FR2993778B1 (fr) * 2012-07-30 2016-06-17 Pf Medicament Pastilles a cinetiques multiples de liberation de principes actifs
CN102926277B (zh) * 2012-11-14 2015-05-20 湖南中烟工业有限责任公司 一种β-环糊精-g-乳酸共聚物的应用
US9375033B2 (en) 2014-02-14 2016-06-28 R.J. Reynolds Tobacco Company Tobacco-containing gel composition
AU2016211330A1 (en) 2015-01-28 2017-08-03 Chrono Therapeutics Inc. Drug delivery methods and systems
US10679516B2 (en) 2015-03-12 2020-06-09 Morningside Venture Investments Limited Craving input and support system
US20170172995A1 (en) * 2015-09-08 2017-06-22 Venkateswara Rao Repaka Pharmaceutical compositions of Nicotine and process for preparation thereof
US20170165252A1 (en) 2015-12-10 2017-06-15 Niconovum Usa Inc. Protein-enriched therapeutic composition
CA3049529A1 (fr) 2017-01-06 2018-07-12 Chrono Therapeutics Inc. Dispositifs et methodes d'administration transdermique de medicament
WO2019110072A1 (fr) * 2017-12-08 2019-06-13 Fertin Pharma A/S Comprimé de nicotine
US11596779B2 (en) 2018-05-29 2023-03-07 Morningside Venture Investments Limited Drug delivery methods and systems
CN112367978A (zh) 2018-07-13 2021-02-12 麦克内尔股份公司 包含尼古丁的口香糖
US12397141B2 (en) 2018-11-16 2025-08-26 Morningside Venture Investments Limited Thermally regulated transdermal drug delivery system
WO2021144367A1 (fr) 2020-01-15 2021-07-22 Mcneil Ab Pastille
SE544672C2 (en) * 2020-05-07 2022-10-11 Liw Innovation Ab New compositions for oral or nasal use
CA3236026A1 (fr) * 2021-10-21 2023-04-27 Mcneil Ab Gomme a macher a base de nicotine

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3877468A (en) * 1970-07-22 1975-04-15 Leo Ab Chewable tobacco substitute composition
US3901248A (en) * 1970-07-22 1975-08-26 Leo Ab Chewable smoking substitute composition
US3845217A (en) * 1972-11-16 1974-10-29 Helsingborg L Ab Buffered smoking substitute compositions
GB8301659D0 (en) * 1983-01-21 1983-02-23 Leo Ab Smoking substitutes
US5783207A (en) * 1985-05-01 1998-07-21 University Of Utah Research Foundation Selectively removable nicotine-containing dosage form for use in the transmucosal delivery of nicotine
GB8615676D0 (en) * 1986-06-26 1986-07-30 Stoppers Co Ltd Nicotine containing lozenge
US5004651A (en) * 1989-01-24 1991-04-02 Abbott Laboratories Stabilizing system for solid dosage forms
US5824334A (en) * 1989-09-05 1998-10-20 University Of Utah Research Foundation Tobacco substitute
US5167242A (en) * 1990-06-08 1992-12-01 Kabi Pharmacia Aktiebolaq Nicotine-impermeable container and method of fabricating the same
EP0620706A1 (fr) * 1992-01-06 1994-10-26 E.I. Du Pont De Nemours And Company Composition de comprime comportant un agent deshydratant incorpore
SE9303574D0 (sv) * 1993-11-01 1993-11-01 Kabi Pharmacia Ab Composition for drug delivery and method the manufacturing thereof
US5889028A (en) * 1996-02-09 1999-03-30 Mayo Foundation For Medical Education And Research Colonic delivery of nicotine to treat inflammatory bowel disease
US5810081A (en) * 1997-02-24 1998-09-22 Cobb; Delwin E. Wear structure for bore hole separation device
US6264981B1 (en) * 1999-10-27 2001-07-24 Anesta Corporation Oral transmucosal drug dosage using solid solution
US20030175349A1 (en) * 2001-01-30 2003-09-18 Council Of Scientific And Industrial Research Pharmaceutical compostion for extended/sustained release of a therapeutically active ingredient
SE0102197D0 (sv) * 2001-06-20 2001-06-20 Pharmacia Ab New product and use and manufacture thereof
US20040037879A1 (en) * 2001-11-02 2004-02-26 Adusumilli Prasad S. Oral controlled release forms useful for reducing or preventing nicotine cravings
EP1501546B1 (fr) * 2002-05-03 2012-10-10 Hexal AG Formulation pharmaceutique stable contenant une statine combinee avec un inhibiteur de l'ace
WO2003101431A1 (fr) * 2002-06-04 2003-12-11 J.B. Chemicals & Pharmaceuticals Ltd. Composition pharmaceutique pour systeme a liberation progressive de medicaments
US20030049307A1 (en) * 2002-08-15 2003-03-13 Gyurik Robert J. Pharmaceutical composition
US20040052851A1 (en) * 2002-09-16 2004-03-18 Graff Allan H. Modified release oral dosage form

Also Published As

Publication number Publication date
RU2448707C2 (ru) 2012-04-27
EP2023928A4 (fr) 2012-08-29
KR20090024161A (ko) 2009-03-06
CA2652500C (fr) 2014-07-29
WO2007133141A1 (fr) 2007-11-22
BRPI0712068A2 (pt) 2012-01-17
JP5254213B2 (ja) 2013-08-07
CN101472591A (zh) 2009-07-01
RU2008149508A (ru) 2010-06-27
US20070269492A1 (en) 2007-11-22
NZ572758A (en) 2011-01-28
EP2023928A1 (fr) 2009-02-18
JP2009537514A (ja) 2009-10-29
AU2007250589A1 (en) 2007-11-22
AR060931A1 (es) 2008-07-23
CA2652500A1 (fr) 2007-11-22
TW200810755A (en) 2008-03-01
MX2008014726A (es) 2009-02-04
ZA200810618B (en) 2010-02-24
AU2007250589B2 (en) 2011-04-14
KR101414063B1 (ko) 2014-07-18

Similar Documents

Publication Publication Date Title
NO20084987L (no) Belagt farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel
MX2009012484A (es) Formulacion de nicotina oral recubierta regulada con aminoacido.
NO20084992L (no) Farmasoytisk produkt for intraoral avlevering av nikotin innbefattende trometamol som bufringsmiddel
NO20084752L (no) Konjugater av aziridinayl-epotilonanaloger og farmasoytiske sammensetninger som inneholder disse
WO2009141321A3 (fr) Gommes à mâcher pouvant être conditionnées en comprimés
BR112021018054A2 (pt) Composição de tabaco, método para produção da composição de tabaco, uso de uma composição de tabaco, artigo para uso em um sistema de fornecimento de aerossol e sistema
NO20084541L (no) Fuktig snussammensetning som ikke inneholder tobakk og fremgangsmate for fremstilling derav
WO2008069970A3 (fr) Formulations de nicotine, trousses, systèmes et procédés d'utilisation
AR078417A1 (es) Composiciones de pelicula sublingual y bucal
EA201071040A1 (ru) Новые производные 1-бензил-3-гидроксиметилиндазола и их применение при лечении заболеваний, обусловленных экспрессией mcp-1, cx3cr1 и p40
AR034527A1 (es) Nuevo producto y uso y fabricacion del mismo
MY164646A (en) Nicotine lozenge compositions
UA106098C2 (uk) Аерозольна композиція для хозл
MX2008010172A (es) Suministro pulmonar de inhibidor de proteinasa alafa-i.
AU2009215514A9 (en) Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
WO2014093127A3 (fr) Administration perfectionnée de nicotine, de thc, de tabac, de cannabidiol ou d'alcaloïde sous forme de base à partir d'une cigarette électronique ou d'un autre dispositif produisant de la vapeur ou de la fumée grâce à l'utilisation d'une unité de conditionnement par absorption
MX2009011862A (es) Composiciones farmaceuticas de administracion oronasofaringea de agonistas de la dopamina para la prevencion/alivio y/o tratamiento del desorden de miembros inquietos.
EA201170520A1 (ru) Ингибитор p38 mapk-киназы
MX2007004495A (es) Composiciones y procedimientos para la administracion intranasal, bucal, sublingual y pulmonar de vareniclina.
MX2010003923A (es) Formulacion farmaceutica de valsartan.
UA98839C2 (en) N,n-disubstituted aminoalkylbiphenyl antagonists of prostaglandin d2 receptors
CL2008001301A1 (es) Compuestos derivados de heterociclos de nitrogeno; procedimiento de preparacion; composicion farmaceutica; y uso del compuesto en el tratamiento de una condicion inflamatoria o alergica, tal como una enfermedad inflamatoria u obstructiva de las vias respiratorias mediada por el bloqueo del canal de sodio epitelial.
EA200970585A1 (ru) Бензамидные производные как агонисты ер-рецепторов
NO20090407L (no) Aerosolformulering for inhalering av beta agonister
NO20075111L (no) Farmasoytisk sammensetning

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application